
CME Group (CME) Stock Forecast & Price Target
CME Group (CME) Analyst Ratings
Bulls say
CME Group has demonstrated a robust revenue growth of approximately 8.1% year-over-year, reaching total revenue of $1,649 million, while its Market Data segment has experienced an impressive growth rate of 14.5%, driven by an influx of new users and effective pricing strategies. The company's commitment to returning value to shareholders is evident, as it has increased its quarterly dividend payments for 14 consecutive years, supported by strong free cash flow generation. Furthermore, the average daily volume (ADV) has exhibited a compound annual growth rate of over 7% from FY16 through FY24, showcasing continuous customer demand and product innovation, which are expected to further enhance revenue growth moving forward.
Bears say
CME Group faces significant headwinds that negatively impact its financial outlook, including a projected 10% decline in FY27 earnings per share (EPS) and anticipated revenue growth of only 5.4% year-over-year, which falls short of the consensus estimate of 6.0%. Heightened competitive threats and a decline in trading volume for interest rate futures, due to a forthcoming rate-cutting cycle, exacerbate concerns over pricing pressures and limited margin improvement. Furthermore, increased regulatory scrutiny could further diminish trading volumes, adding to the company's challenges in maintaining its revenue and profitability amidst an evolving market landscape.
This aggregate rating is based on analysts' research of CME Group and is not a guaranteed prediction by Public.com or investment advice.
CME Group (CME) Analyst Forecast & Price Prediction
Start investing in CME Group (CME)
Order type
Buy in
Order amount
Est. shares
0 shares